PAIN EAST TOPICAL ANESTHETIC SKIN REFRIGERANT 0396-0008-04

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2011-08-12 for PAIN EAST TOPICAL ANESTHETIC SKIN REFRIGERANT 0396-0008-04 manufactured by Gebauer Co..

Event Text Entries

[20739962] A gebauer co. Sales rep was in-servicing a doctor's office and was demonstrating gebauer's pain ease topical anesthetic skin refrigerant. A (b)(6), female nurse experienced a seizure shortly after being sprayed topically for 2 to 3 seconds with pain ease. The seizures lasted approx 2 to 3 min. Cpr was performed and the nurse was hospitalized for 24 hrs. While in the emergency dept, the nurse had a second seizure. As reported, the nurse returned to work within a week and had no impairment.
Patient Sequence No: 1, Text Type: D, B5


[20911320] Due to the serious nature of the adverse event, gebauer co is reporting the event to the fda, but does not believe it is likely that gebauer's pain ease caused or contributed to the adverse event. This conclusion is based on the following: no other similar complaints have been reported to gebauer since the introduction of the product in 2002; the two ingredients used in pain ease are commonly used halogenated hydrocarbons and the toxicity data has been reviewed by the u. S. Epa as well as the fda and no instances of seizures at dosing done at high concentrations and extended dosing periods (up to two yrs) have been reported. Toxicity studies were conducted for both inhalation and dermal routes of exposure; toxicity studies performed by gebauer on the products specific formulation were conducted and no reports of seizures were identified during product testing and the safety data was submitted during the 510 (k) process; the nurse reported that her physician had taken her off of trileptal (oxcarbacine) the week prior to the adverse event. The medication guide for trileptal identifies that seizures can occur when the medication is stopped; and the nurse experienced another seizure while at the emergency dept and there was no exposure to pain ease. Multiple seizures after stopping tirleptal is also identified in the medication guide for the drug as a possible side effect. Based on the safety testing conducted on the ingredients of gebauer's pain ease, the nurse's medical history, and being taken off trileptal shortly before the adverse event, it is unlikely that gebauer's pain ease caused or contributed to the adverse event.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1519179-2011-00001
MDR Report Key2230597
Report Source07
Date Received2011-08-12
Date of Report2011-09-11
Date of Event2011-06-29
Date Mfgr Received2011-06-29
Device Manufacturer Date2010-12-29
Date Added to Maude2011-09-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer Street4444 E. 153RD ST.
Manufacturer CityCLEVELAND OH 44128
Manufacturer CountryUS
Manufacturer Postal44128
Manufacturer Phone2165813030
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePAIN EAST TOPICAL ANESTHETIC SKIN REFRIGERANT
Generic NameVAPOCOOLANT
Product CodeMLY
Date Received2011-08-12
Model Number0396-0008-04
Lot Number9758
Device Expiration Date2012-12-31
OperatorOTHER
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerGEBAUER CO.
Manufacturer AddressCLEVELAND OH 44128 US 44128


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2011-08-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.